WO2017092176A1 - 一种美白抗皱中药组合物及其混合提取物和应用 - Google Patents

一种美白抗皱中药组合物及其混合提取物和应用 Download PDF

Info

Publication number
WO2017092176A1
WO2017092176A1 PCT/CN2016/073392 CN2016073392W WO2017092176A1 WO 2017092176 A1 WO2017092176 A1 WO 2017092176A1 CN 2016073392 W CN2016073392 W CN 2016073392W WO 2017092176 A1 WO2017092176 A1 WO 2017092176A1
Authority
WO
WIPO (PCT)
Prior art keywords
chinese medicine
medicine composition
wrinkle
extract
mixed extract
Prior art date
Application number
PCT/CN2016/073392
Other languages
English (en)
French (fr)
Inventor
朱华结
查建生
吴结祥
徐金荣
何艺
Original Assignee
南京斯拜科生化实业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南京斯拜科生化实业有限公司 filed Critical 南京斯拜科生化实业有限公司
Publication of WO2017092176A1 publication Critical patent/WO2017092176A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Definitions

  • the invention relates to the field of Chinese herbal medicine compositions, in particular to a natural whitening anti-wrinkle Chinese medicine composition with multi-target whitening mechanism and a mixed extract thereof and application thereof.
  • the pursuit of beauty by centuries changes with the changes of the times. Some of the most basic and difficult ones are people's pursuit of the beauty of the face. For the Asian population, there are several aspects: whitening, moisturizing, anti-wrinkle, and the product can not stimulate the facial skin.
  • a whitening anti-wrinkle Chinese medicine composition of the present invention comprises gastrodia elata, white peony root, paeonol, ginseng, safflower, notoginseng, salvia, licorice, and alfalfa; wherein the weight of white peony, salvia, licorice It accounts for 30 to 55% of the total weight.
  • Gastrodia elata is often used in the treatment of high fever or cerebrovascular disease caused by convulsions in children, convulsions, headache, dizziness, dark eyes, limb paralysis, numbness, poor language, hemiplegia, etc.
  • the invention uses Tianma to promote the expansion of cortical blood vessels, nutrition cortex Nerve, synergistic effect on whitening main drugs.
  • White peony traditional Chinese pharmacy is mainly used to stagnate hemostasis and reduce swelling and muscle growth.
  • the invention removes the residual stem and the fibrous root, washes it, boils it to boiling water until no white heart, removes the outer skin, dried and sliced for use; and together with the tan skin and the licorice as the main medicine for whitening effect.
  • Danpi also known as peony bark
  • peony bark is a Chinese medicine name.
  • Traditional Chinese medicine believes that Danpi can clear heat and cool blood, and promote blood circulation.
  • Modern studies have shown that paeonol and other glycoside components contained in paeonol have anti-inflammatory effects.
  • the paeonol used in the present invention is a peony root bark, which is dried and pulverized after being washed. In the present invention, not only its whitening effect but also the metabolism of skin cells promotes synergistic effect.
  • Ginseng sweet and bitter, slightly bitter, with great vitality, spleen and stomach, Shengjin liquid, thirst quenching, soothe the nerves, anti-aging Life and other functions.
  • the invention adopts the root of ginseng, is washed, dried and pulverized for use, and is used in the invention to promote microcirculation of skin blood vessels and to nourish skin cells.
  • it is pulverized after being dried in the shade, and the use on the skin can promote the vitality of the skin cells and maintain the normal water metabolism of the cells.
  • Panax notoginseng is mainly used for relieving blood stasis, reducing swelling and pain. It can promote microcirculation of epidermal blood vessels and improve the vitality and function of skin cells.
  • Salvia miltiorrhiza has the effect of promoting blood circulation, relieving pain, clearing heart and removing trouble, cooling blood and eliminating phlegm.
  • Modern pharmacy is based on Salvia miltiorrhiza, which significantly increases coronary blood flow, significantly reduces coronary resistance, improves myocardial function, and achieves significant results in the treatment of coronary heart disease and relief of angina pectoris.
  • the salvia miltiorrhiza used in the present invention selects its root, washes it, drys it, and pulverizes it for use.
  • Salvia miltiorrhiza has various functions in the present invention, not only a mild antibacterial and anti-inflammatory component, but also promotes microcirculation of skin cells and nourish skin cells.
  • Licorice choose its roots, dry and smash. The air is slight, sweet and special. Indications for heat and detoxification, phlegm and cough, abdominal abdomen and so on.
  • Licorice contains a variety of chemical components, glycyrrhizin and flavonoids are the most important physiologically active substances in licorice, mainly in the parts of the licorice root epidermis. Licorice not only can provide a certain whitening effect, but also can be used in the strip and the various components of the formula.
  • cockroaches are mainly used for moisturizing and nourishing skin cells, and improving microcirculation of skin cells.
  • Astragalus membranaceus is a perennial herb of the genus Astragalus, which is selected from its roots and dried and smashed. Chinese medicine believes that jaundice tastes bitter cold, into the lungs, heart, gallbladder, large intestine, has the function of clearing heat and dampness, purging fire and detoxification, and curing the fetus. It is hot and cold, chest tightness, vomiting, lung heat cough, blood heat, high fever and polydipsia It has good effects such as dampness and heat. Modern research has proved that the components of Astragalus membranaceus have a broad spectrum of antibacterial activity.
  • the components of Astragalus membranaceus have an anti-inflammatory effect on microorganisms floating or attached to the air.
  • the above composition obtains a highly reducible substance by a specific extraction process, and has excellent in vitro antioxidant ability.
  • white peony, paeonol and licorice are the main components of their whitening action, and can effectively inhibit tyrosine kinase activity.
  • Ginseng, notoginseng and salvia miltiorrhiza promote skin microcirculation, and long-term use can improve skin cells.
  • the test proved that the activity of the composition inhibiting tyrosine kinase was similar to that of arbutin when ginseng, notoginseng and salvia miltiorrhiza were not included.
  • the IC 50 value decreased by about 20%, indicating that the group The split has a promoting effect on whitening.
  • the traditional Chinese medicine composition comprises the following components in mass percentage:
  • white peony, paeonol and licorice are the main medicines for whitening.
  • Salvia miltiorrhiza, ginseng and notoginseng provide rich nutrient factors and promote microcirculation, which plays a nutritional role and has a synergistic effect on whitening.
  • the safflower has a certain moist and water-retaining effect, promotes the vitality of the skin cells, and has a good nutritional effect as a fruit and promotes microcirculation.
  • Astragalus and Salvia miltiorrhizae are the components of the antibacterial and anti-inflammatory activity in the composition.
  • the warm Danshen is the main component, and the Astragalus is the supplement.
  • Gastrodia elata enhances the mildness of the composition on the skin and synergizes with the nutrient layer.
  • the pharmaceutical composition is 5.1% by mass, 10.2% of peony, 6.5% of peony, 2.6% of ginseng, 12.8% of safflower, 6.4% of safflower, 6.4% of ginseng, 12.8% of salvia miltiorrhiza, and licorice 19.2. %, ⁇ 19.3%, and ⁇ ⁇ 5.1%.
  • the pharmaceutical composition is composed of gastrodia stannum 5.3%, white peony 6.6%, paeonol 6.6%, ginseng 0.65%, safflower 13.2%, panax notoginseng 6.6%, salvia miltiorrhiza 13.2%, licorice 17.1%, ⁇ 26.3%, and ⁇ ⁇ 5.3%.
  • the pharmaceutical composition is 5.1% by mass, 10.2% of peony, 6.4% of peony, 2.6% of ginseng, 12.8% of safflower, 6.4% of safflower, 4.4% of salvia, 12.8 of danshen, and licorice 19.2. %, ⁇ 19.2%, and jaundice 5.1%.
  • an extract is obtained by a specific method for use in adding a cosmetic.
  • a mixed extract of a whitening anti-wrinkle Chinese medicine composition obtained by the following method: the traditional Chinese medicine according to claim 1.
  • the composition is mixed in proportion, pulverized and extracted by alcohol, and refluxed to obtain a preliminary extract; the preliminary extract is wet-column and separated by diatomaceous earth column chromatography.
  • the alcohol extraction is carried out at a ratio of alcohol:water of 10:90 at 69 to 90 ° C for 6 to 8 hours, and the extract is subjected to reflux extraction, allowed to stand, concentrated, and dried until the solvent is completely evaporated.
  • chromatographically through diatomaceous earth an ethanol-ethyl acetate system was used, and the volume ratio of ethanol to ethyl acetate was from 2:1 to 1:15.
  • the invention utilizes a diatom system for chromatography, and is a non-toxic and non-sensitizing system relative to other materials, does not introduce toxic small molecular dust and impurities; and has high purification efficiency.
  • the mixed extract contains scorpion and glycoside substances in a total weight of not less than 18%.
  • the antioxidant activity calculated by the above-mentioned extract after reacting with DPPH for 1 hour and the blank control was not less than 94%; the tyrosine kinase inhibitory ability was 70% or more at 0.1% g/mL.
  • the method for calculating the antioxidant rate and the tyrosine kinase inhibitory ability according to the present invention will be further described in the test examples of the specific embodiments.
  • the traditional Chinese medicine composition of the present invention can be used for preparing a cosmetic, and a high concentration of the active ingredient extract is obtained by the above process, and the amount is generally 1 to 10%.
  • the whitening effect is good, for example, at 0.1% g/mL, the ability to inhibit tyrosine kinase is more than 70%;
  • the active ingredient shows almost no toxicity, for example, the toxic effect on B16 cells, and its CC 50 value is substantially greater than 1000 ug/mL.
  • the invention combines the traditional natural Chinese medicine formulas innovatively, and the mixed extract obtained by the related preparation process has the effects of whitening, anti-oxidation, moisturizing and promoting collagen growth, safe and non-toxic, high affinity and no stimulation.
  • Figure 1 is a graph showing the results of SEr in the wrinkle improvement test of Test Example 7 of the present invention.
  • Figure 2 is a graph showing the results of SEsm in the wrinkle improvement test of Test Example 7 of the present invention.
  • Fig. 3 is a graph showing the results of SEw in the wrinkle improvement test of Test Example 7 of the present invention.
  • a whitening anti-wrinkle Chinese medicine composition including gastrodia elata, white peony root, paeonol, ginseng, safflower, panax notoginseng, salvia miltiorrhiza, licorice, and alfalfa; wherein the weight of white peony, salvia, licorice accounts for 30 to 55% of the total weight, At 15% of the total weight, safflower accounts for 8-20% of the total weight, and Tianma does not exceed 8% of the total weight.
  • a whitening anti-wrinkle Chinese medicine composition according to the mass percentage, 3 to 6% of gastrodia, 5 to 15% of white peony, 5 to 15% of danshen, 1 to 5% of ginseng, 10 to 15% of safflower, and 2 to 8% of ginseng , Danshen 8 ⁇ 18%, licorice 15 ⁇ 35%, ⁇ 15 ⁇ 40%, Astragalus 2 ⁇ 8% composition.
  • the mixed extracts are prepared by using the above-mentioned traditional Chinese medicine composition, the above components are mixed in proportion, pulverized, extracted by alcohol, and refluxed to obtain a preliminary extract; the preliminary extract is wet-column and separated by silica gel column chromatography.
  • Gastrodia is selected from its roots, washed, dried, and crushed.
  • White cockroaches go out to remnant stems and fibrous roots, wash, boil water to no white heart, remove the skin, dry, slice and use.
  • Danpi is the root of peony, washed, dried, and crushed.
  • Ginseng uses its roots, washed, dried, and crushed.
  • the safflower is selected from the genus Asteraceae, washed, dried, and crushed.
  • Sanqi uses roots and stems, washed, dried, and crushed.
  • the licorice uses its roots and is dried and smashed. ⁇ Select the fruit, smash it after drying.
  • Astragalus sinensis is selected from the roots, dried and smashed.
  • a whitening anti-wrinkle Chinese medicine composition which is 5.1% by mass, 10.2% of white peony, 6.5% of peony, 2.6% of ginseng, 12.8% of safflower, 6.4% of safflower, 12.8% of salvia miltiorrhiza, 12.8% of danshen, 19.2% of licorice, ⁇ 19.3. %, Huang Qi 5.1% composition.
  • a whitening anti-wrinkle Chinese medicine composition which is composed of gastrodia stannum 5.3%, white peony 6.6%, paeonol 6.6%, ginseng 0.65%, safflower 13.2%, panax notoginseng 6.6%, salvia miltiorrhiza 13.2%, licorice 17.1%, ⁇ 26.3 %, Huang Qi 5.3% composition.
  • a whitening anti-wrinkle Chinese medicine composition which comprises 5.1% of gastrodia elata, 10.2% of white peony, 6.4% of paeonol, 2.6% of ginseng, 12.8% of safflower, 6.4% of ginseng, 12.8 of salvia miltiorrhiza, 12.2% of licorice, 19.2% of licorice. , Huang Qi 5.1% composition.
  • an extract is obtained by a specific method for use in adding a cosmetic.
  • a mixed extract of a whitening anti-wrinkle Chinese medicine composition obtained by the following method: mixing the traditional Chinese medicine composition according to claim 1 in proportion, pulverizing, extracting alcohol, refluxing and extracting to obtain a preliminary extract; and applying the preliminary extract to the wet method
  • the column was obtained by chromatography on a celite column.
  • the alcohol extraction is carried out at a ratio of alcohol:water 10:90 at 69-90 ° C for 6-8 hours, and the extract is subjected to reflux extraction, then allowed to stand, concentrated, and dried until the solvent is completely evaporated.
  • chromatographically through diatomaceous earth an ethanol-ethyl acetate system was used, and the volume ratio of ethanol to ethyl acetate was from 2:1 to 1:15.
  • the mixed extract contains scorpion and glycoside substances in a total weight of not less than 18%. After 1 hour of reaction with DPPH, the calculated antioxidant rate was not less than 94% with the blank control assay; the tyrosine kinase inhibitory ability was over 70% at 0.1% g/mL.
  • Test Example 1 Toxicity of sample to B16 cells
  • B16 cells were mixed with different concentrations of traditional Chinese medicine mixed extract solution, three replicate wells were set, and a drug-free blank control was set at 37 ° C, 5% CO 2 for 24 h, using MTS ratio.
  • the cytotoxicity was measured by a color method, and the OD value was measured by a microplate reader to measure a wavelength of 490 nm.
  • the calculated CC 50 values are shown in Table 1:
  • Test Example 2 Antioxidation of samples in vitro
  • the experimental group was mixed with DPPH (final concentration: 100 M), and three replicate wells were set. At the same time, a blank control and a Trolox positive control containing no extract were set, and the reaction was carried out at 30 ° C for 1 hour. The OD value and the detection wavelength were measured by a microplate reader. For 515 nm, the antioxidant rate was calculated.
  • Antioxidation rate (%) (1 - experimental hole OD 515nm / blank hole OD 515nm ) ⁇ 100%
  • test results show that all three have good in vitro antioxidant capacity, and the antioxidant rate of vitamin E is equivalent, which can effectively remove free radicals in the body and prevent skin aging.
  • Extract A The extract was obtained by the same procedure as in Example 3 except that the components were substantially the same as those of Example 3, but did not contain Salvia miltiorrhiza.
  • Extract B The extract of Salvia miltiorrhiza and danshen of the same quality as in Example 3 was obtained by Example 6.
  • the experimental group, extract A and extract B were mixed with DPPH (final concentration of 100 M), and three replicate wells were set. At the same time, a blank control containing no extract and a Trolox positive control were set, and reacted at 30 ° C for 1 hour. The OD value was measured by a microplate reader, and the detection wavelength was 515 nm. The method for calculating the antioxidant rate was the same as in Test Example 2.
  • the drug to be tested was mixed with L-Dopa (final concentration 1.25 mM), tyrosinase (final concentration 25 U/mL) was added to start the reaction, and 3 replicate wells were set, and a drug-free blank control and Kojic Acid-positive were set. Control, room temperature, 5 min, the OD value was measured by a microplate reader, and the detection wavelength was 490 nm. The inhibition rate of tyrosinase activity was calculated.
  • Tyrosinase activity inhibition rate (%) [1- (sample OD 490nm - background control sample OD 490nm) / control well OD 490nm experiment] ⁇ 100%
  • Extract C substantially the same components as in Example 3, but without ginseng, notoginseng and salvia miltiorrhiza, an extract obtained by Example 6; extract D: ginseng, notoginseng and the same quality as the formulation of Example 3 Salvia miltiorrhiza obtained the extract by Example 6.
  • HDFa cells were mixed with different concentrations of the drug solution to be tested, and a drug-free blank and a TGF- ⁇ positive control were set. Incubate at 37 ° C, 5% CO 2 for 3 days, collect the cell culture supernatant, store at -80 ° C; add MTS, use MTS colorimetric method to detect OD value at 490 nm; detect collagen according to the method provided in collagen ELISA kit The secretion was measured by a microplate reader, and the detection wavelength was 450 nm. The rate of increase in collagen secretion was calculated.
  • Collagen secretion increase rate (experimental well OD 450nm / cell viability / blank well OD 450nm -1) ⁇ 100%
  • a mixed extract of 5% of the aforementioned traditional Chinese medicine composition (Example 5) was added for the preparation of a conventional eye cream, and the cream was applied to the corners of the eye to perform an anti-wrinkle improvement test for evaluation of the effect.
  • Test site eye corner
  • Test parameters 1. Skin texture scanner Visioscan VC98 is used to detect skin roughness SEr, smoothness SEsm and wrinkle SEw; the smaller the above measured value, the smaller the skin roughness, the smoother the skin, the smaller the skin wrinkles; Questionnaires were used to conduct self-assessment of subjects. The scoring criteria were: 5 for “very satisfied”, 4 for “satisfactory”, 3 for “general”, 2 for “less satisfied”, and 1 for “ Not satisfied.”
  • the questionnaire is filled in and photographed.
  • the subject needs to self-assess the skin of the test site 4 weeks after the product is used and 8 weeks after the product is used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

一种美白抗皱中药组合物及其混合提取物和应用，所述组合物包括天麻，白芨，丹皮，人参，红花，三七，丹参，甘草，枸杞，和黄芩，所述组合物的混合提取物可抑制酪氨酸激酶，具有抗氧化作用，促进胶原蛋白生长，并用于化妆品。

Description

一种美白抗皱中药组合物及其混合提取物和应用 技术领域
本发明涉及中草药组合物领域，具体地说涉及一种以多靶点美白为机理的天然美白抗皱中药组合物及其混合提取物和应用。
背景技术
人类对于美的追求，是随着时代的变迁而变化。其中一些最基本的，也是最难的则是人们对于面部的美的追求。对于亚洲人群来讲，主要包括几个方面：美白、保湿、抗皱，同时要求产品不能对面部皮肤有刺激。
近年来，人们对化妆品的认知度逐步提高，对一种化妆品拥有多种美容功效的需求也越来越大，而且对化妆品原料的来源和使用安全性也越来越重视。目前已有多种中草药被人们发现具有一定的美白效果，但大多停留在对其美白组分的探索，没有结合传统中药学理论和现代工艺获得多功效的产品。尤其在化妆品领域，目前还没有保证优秀美白效果同时，附加营养吸收、抗皱润肤的效果。
发明内容
发明目的：本发明的目的是提供一种兼顾美白、抗皱、抗氧化的天然中药组合物，本发明还有一个目的是提供前述组合物的混合提取物及在制备外用化妆品上的应用。
技术方案：为了实现上述发明目的，本发明的一种美白抗皱中药组合物，包括天麻、白芨、丹皮、人参、红花、三七、丹参、甘草、枸杞；其中白芨、丹参、甘草的重量占总重的30～55％。
以下对本发明所采用的中草药进行说明：
天麻常用于治病高热或脑血管疾患引起的小儿惊风、抽搐、头痛、眩晕、眼黑、肢体痉挛、麻木、语言不畅、半身不遂等症，本发明选用天麻是促进皮层血管的扩张，营养皮层神经，对美白主药协同增效。
白芨，传统中药学上主要用于收敛止血，消肿生肌。本发明将其除除去残茎及须根，洗净，置沸水煮至无白心，除去外皮，晒干，切片生用；与丹皮、甘草共同作为美白功效的主药。
丹皮，又名牡丹皮，中药名。为毛茛科植物牡丹干燥的根皮。中药学认为丹皮可以清热凉血，活血散瘀。现代研究表明，丹皮中所含的丹皮酚及其以外的糖苷类成分均有抗炎作用。本发明所用丹皮为牡丹根皮，洗净后阴干、粉碎待用，在本发明中不仅其美白的作用，还促进皮肤细胞代谢，起协同增效的作用。
人参，性温味甘微苦，具有大补元气、健脾胃、生津液、止渴、安神宁心、抗老延 寿等作用。含多种皂甙和多糖类成分，不仅可以改善人的肌肤，用于护肤美容，还是名贵的滋补药。本发明采用人参的根部，洗净、阴干后粉碎待用，在本发明中用于促进皮肤血管微循环，营养皮肤细胞。
红花，菊科红花属植物，活血通经，散瘀止痛，有助于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛疗效。在本发明中阴干后粉碎，在皮肤上配伍使用可促进皮肤细胞活力，保持细胞正常水分代谢。
三七，选用其根茎，洗净、阴干后粉碎。三七主要用于散瘀止血，消肿定痛。可促进表皮血管微循环，改善皮肤细胞的活力与功能。
丹参，具有活血祛瘀，通经止痛，清心除烦，凉血消痈之功效。现代药学以丹参为主药，使病人冠脉血流量明显增加，冠脉阻力明显下降，改善了心肌功能，在治疗冠心病、缓解心绞痛方面取得了明显的效果。本发明所用丹参选用其根，洗净、阴干后粉碎待用。丹参在本发明中具有多种功效，不仅是温和的抗菌消炎成分，还可促进皮肤细胞微循环和营养皮肤细胞。
甘草，选用其根茎，晾干后粉碎。气微，味甜而特殊。功能主治清热解毒、祛痰止咳、脘腹等。甘草含有多种化学成分，甘草甜素和黄酮类物质是甘草中最重要的生理活性物质，主要存在于甘草根表皮以内的部分。甘草不仅能起到一定的美白功效，同时能条和配方中各个组分。
枸杞选用其果实，晒干后粉碎使用。枸杞子味甘性平，“入足少阴兼厥阴经血分，补肝经之阴，益肾水之阳。”其具有滋补肝肾，益精养血，明目消翳，润肺止咳的作用。主治肾虚骨痿，阳痿遗精，久不生育，早老早衰，须发早白，血虚萎黄，产后乳少，目暗不明，内外障眼，内热消渴，劳热骨蒸，虚痨咳嗽，干咳少痰等病证。药理学研究证实，枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖等方面的作用。本发明中枸杞主要用于皮肤细胞的滋润与营养，并改善皮肤细胞的微循环。
黄芩，是唇形科黄芩属多年生草本植物，选用其根茎，晾干、粉碎。中医认为黄芩味苦性寒，入肺、心、胆、大肠经，有清热燥湿、泻火解毒、安胎的功能，对暑温胸闷呕吐、肺热咳嗽、血热妄行、高热烦渴、湿热下痢等有良好功效。现代研究证明，黄芩的成分具有较广的抗菌谱，在本发明中作为较强的抗菌消炎活性成分，黄芩的成分对空气中漂浮或附着的微生物具有消炎作用。而上述组合物通过特定的提取工艺获得了具有高还原性的物质，具有非常好的体外抗氧化能力。
本发明中药组合物的各组分中，白芨、丹皮和甘草是其美白作用的主要成分，可有效抑制酪氨酸激酶活性。人参、三七和丹参促进皮肤微循环，长期使用可改善皮肤细胞。 试验证明，不含有人参、三七和丹参时，组合物抑制酪氨酸激酶的活性与熊果苷较为接近，加入上述三个组分后，IC50的值下降了20％左右，表明其组分对美白具有促进效果。另一方面，试验证明，丹参和丹皮的加入显著提高了组合物中抗氧化活性。为了保证各个组分有机地组合并发挥各自功效，枸杞不少于总重的15％，红花占总重的8～20％，天麻不超过总重的8％。
作为本发明的优选方案，该中药组合物按质量百分比包括如下组分：
Figure PCTCN2016073392-appb-000001
其中白芨、丹皮和甘草为美白的主药，丹参、人参和三七提供较丰富的营养因子并促进微循环，起到营养作用，并对美白有增效。红花具有一定的湿润、保水效果，促进皮肤细胞活力，枸杞作为果实用药具有较好的营养功效，促进微循环。黄芩和丹参作为组合物中其抗菌消炎活性的组分，温性的丹参为主，黄芩为辅。而天麻增强了组合物在皮肤上使用的温和性，协同营养皮层。
作为本发明的一种优选方式，其中药组合物按质量百分比由天麻5.1％，白芨10.2％，丹皮6.5％，人参2.6％，红花12.8％，三七6.4％，丹参12.8％，甘草19.2％，枸杞19.3％，黄芩5.1％组成。
作为本发明的另一种优选方式，其中药组合物按质量百分比由天麻5.3％，白芨6.6％，丹皮6.6％，人参0.65％，红花13.2％，三七6.6％，丹参13.2％，甘草17.1％，枸杞26.3％，黄芩5.3％组成。
作为本发明的另一种优选方式，其中药组合物按质量百分比由天麻5.1％，白芨10.2％，丹皮6.4％，人参2.6％，红花12.8％，三七6.4％，丹参12.8，甘草19.2％，枸杞19.2％，黄芩5.1％组成。
将上述中药组合物按照一定比例后，通过特定方法制得提取物，用于加入化妆品中。一种美白抗皱中药组合物的混合提取物，通过如下方法获得：将权利要求1所述的中药 组合物按比例混合，粉碎后醇提，回流萃取获得初浸膏；将初浸膏湿法上柱，通过硅藻土柱层析分离获得。
所述中药组合物粉碎后醇提是利用醇：水为10∶90的比例在69～90℃下提取6～8小时，提取液经过回流萃取后静置、浓缩、干燥至溶剂完全挥发。通过硅藻土层析时，采用乙醇-乙酸乙酯体系，乙醇和乙酸乙酯使用的体积比为2∶1～1∶15。本发明利用硅藻体系进行层析，相对于其他材料而言，是一种无毒不致敏的体系，不会引入有毒的小分子尘埃、杂质；且纯化效率高。
该混合提取物中甙类、糖苷类物质占总重不少于18％。
上述提取物与DPPH反应1小时后与空白对照测定计算的抗氧化率不小于94％；0.1％g/mL时酪氨酸激酶抑制能力达到70％以上。本发明所述的抗氧化率和酪氨酸激酶抑制能力的计算方法在具体实施方式的试验例中会进行进一步说明。
本发明的中药组合物可用于制备化妆品，通过上述工艺获得高浓度的活性成分提取物，一般添加量为1～10％。
利用前述中药组合物获得的混合提取物具有如下优势：
(1)美白效果好，例如在0.1％g/mL时，其抑制络氨酸激酶的能力达到70％以上；
(2)抗氧化能力强，同样浓度时，和维生素E相当；
(3)能够显著促进胶原蛋白的生长；
(4)其有效成分几乎表现出没有毒性，例如对B16细胞的毒性作用，其CC50值基本大于1000ug/mL。
本发明将传统的天然中药配方进行创新组合，通过相关制备工艺获的混合提取物同时具备美白、抗氧化、保湿且促进胶原蛋白生长的效果，安全无毒，使用亲和度高，不刺激。
附图说明
图1是本发明试验例7皱纹改善试验中SEr的结果；
图2是本发明试验例7皱纹改善试验中SEsm的结果；
图3是本发明试验例7皱纹改善试验中SEw的结果。
具体实施方式
下面对本发明的具体实施方式进行进一步说明。
实施例1
一种美白抗皱中药组合物，包括天麻、白芨、丹皮、人参、红花、三七、丹参、甘草、枸杞；其中白芨、丹参、甘草的重量占总重的30～55％，枸杞不少于总重的15％，红花占总重的8～20％，天麻不超过总重的8％。
实施例2
一种美白抗皱中药组合物，按质量百分比由天麻3～6％，白芨5～15％，丹皮5～15％，人参1～5％，红花10～15％，三七2～8％，丹参8～18％，甘草15～35％，枸杞15～40％，黄芩2～8％组成。
利用前述中药组合物制备其混合提取物，将上述各组分按比例混合，粉碎后醇提，回流萃取获得初浸膏；将初浸膏湿法上柱，通过硅胶柱层析分离获得。
天麻选用其根，洗净、阴干、粉碎。白芨出去残茎和须根，洗净，煮沸水至无白心，除去外皮，晒干、切片生用。丹皮为牡丹根皮，洗净，阴干，粉碎。人参选用其根，洗净、阴干、粉碎。红花选用菊科红花属，洗净、阴干、粉碎。三七选用根茎部，洗净、阴干、粉碎。甘草选用其根茎，晾干后粉碎。枸杞选用果实，晒干后粉碎。黄芩选用根茎部，晾干后粉碎。
实施例3
一种美白抗皱中药组合物，其按质量百分比由天麻5.1％，白芨10.2％，丹皮6.5％，人参2.6％，红花12.8％，三七6.4％，丹参12.8％，甘草19.2％，枸杞19.3％，黄芩5.1％组成。
实施例4
一种美白抗皱中药组合物，其按质量百分比由天麻5.3％，白芨6.6％，丹皮6.6％，人参0.65％，红花13.2％，三七6.6％，丹参13.2％，甘草17.1％，枸杞26.3％，黄芩5.3％组成。
实施例5
一种美白抗皱中药组合物，其按质量百分比由天麻5.1％，白芨10.2％，丹皮6.4％，人参2.6％，红花12.8％，三七6.4％，丹参12.8，甘草19.2％，枸杞19.2％，黄芩5.1％组成。
实施例6
针对实施例3～5获得的中药组合物，采用如下方法获得混合提取物：
将上述中药组合物按照一定比例后，通过特定方法制得提取物，用于加入化妆品中。一种美白抗皱中药组合物的混合提取物，通过如下方法获得：将权利要求1所述的中药组合物按比例混合，粉碎后醇提，回流萃取获得初浸膏；将初浸膏湿法上柱，通过硅藻土柱层析分离获得。
所述中药组合物粉碎后醇提是利用醇：水10∶90的比例在69～90℃下提取6～8小时，提取液经过回流萃取后静置、浓缩、干燥至溶剂完全挥发。通过硅藻土层析时，采用乙醇-乙酸乙酯体系，乙醇和乙酸乙酯使用的体积比为2∶1～1∶15。
该混合提取物中甙类、糖苷类物质占总重不少于18％。与DPPH反应1小时后与空白对照测定计算的抗氧化率不小于94％；0.1％g/mL时酪氨酸激酶抑制能力达到70％以上。
试验例1 样品对B16细胞的毒性作用
分别将实施例3、4、5的中药组合物通过实施例6的方法制备对应混合提取物，作为实验组用于该试验及其后续试验，对提取物的活性进行综合评估。
96孔细胞培养板上，将B16细胞与不同浓度的中药混合提取物溶液混合，设定3个重复孔，同时设置不含药物的空白对照，37℃，5％CO2培养24h，采用MTS比色法检测细胞毒性，酶标仪测定OD值，测定波长490nm。计算得到CC50值如表1所示：
细胞存活率(％)＝实验孔OD490nm/空白孔OD490nm×100％
表1细胞毒性试验结果
Figure PCTCN2016073392-appb-000002
结果表明，三种混合提取物的CC50均大于1000g/ml，因此表现很小的毒性，对皮肤没有伤害。
试验例2 样品体外抗氧化作用
将实验组与DPPH(终浓度为100M)混合反应，设定3个重复孔，同时设置不含提取液的空白对照和Trolox阳性对照，30℃反应1小时，酶标仪测定OD值，检测波长为515nm，计算得到抗氧化率。
抗氧化率(％)＝(1-实验孔OD515nm/空白孔OD515nm)×100％
表2样品体外抗氧化试验结果
Figure PCTCN2016073392-appb-000003
Figure PCTCN2016073392-appb-000004
试验结果显示，三种均具有很好的体外抗氧化能力，与维生素E的抗氧化率相当，能够有效地清除体内自由基，起到防止皮肤衰老的作用。
试验例3 样品体外抗氧化对比试验
提取物A：与实施例3基本相同的组分，但不含有丹参、丹皮，通过实施例6获得提取物。提取物B：将与实施例3相同质量的丹参和丹皮通过实施例6获得提取物。
将实验组、提取物A和提取物B分别与DPPH(终浓度为100M)混合反应，设定3个重复孔，同时设置不含提取液的空白对照和Trolox阳性对照，30℃反应1小时，酶标仪测定OD值，检测波长为515nm，计算抗氧化率方法与试验例2相同。
表3样品体外抗氧化对比试验结果
实验组 浓度(μg/mL) 抗氧化率(％)
Trolox 100 93.48
实施例3 100 94.59
提取物A 100 83.56
提取物B 100 86.82
试验结果显示：如缺少丹参和丹皮，抗氧化活性是不及VC的，而添加了丹参和丹皮后，抗氧化率高出VC。可见丹参和丹皮在抗氧化性上起到了关键作用。
试验例4 酪氨酸酶抑制实验
将待测药物与L-Dopa(终浓度1.25mM)混合，加入酪氨酸酶(终浓度25U/mL)开始反应，设定3个重复孔，同时设置不含药物的空白对照和Kojic Acid阳性对照，室温，5min，酶标仪测定OD值，检测波长为490nm。计算得到酪氨酸酶活性抑制率。
酪氨酸酶活性抑制率(％)＝〔1-(样品OD490nm-样品本底对照OD490nm)/实验对照孔OD490nm〕×100％
表4酪氨酸酶抑制试验结果
样品 浓度(μg/mL) 酪氨酸酶抑制率(％)
Kojic Acid(曲酸) 100 81.50
实施例3 100 73.33
实施例4 100 74.48
实施例5 100 79.33
由表可知，实例3、4、5得到的提取物均具有很好的酪氨酸酶抑制功能，其中实例5得到的提取物酪氨酸酶抑制率最高达到79.33％。三者的活性与曲酸接近。
试验例5 酪氨酸酶抑制对比实验
提取物C：与实施例3基本相同的组分，但不含有人参、三七和丹参，通过实施例6获得提取物；提取物D：将与实施例3配方相同质量的人参、三七和丹参通过实施例6获得提取物。
将试验例3获得的提取物与前述提取物C和提取物D作为实验组分别与L-Dopa(终浓度1.25mM)混合，加入酪氨酸酶(终浓度25U/mL)开始反应，设定3个重复孔，同时设置不含药物的空白对照和熊果苷阳性对照，室温，5min，酶标仪测定OD值，检测波长为490nm。按照试验例3相同的方法计算得到酪氨酸酶活性抑制率。
表5酪氨酸酶抑制对比试验结果
样品 浓度(μg/mL) 酪氨酸酶抑制率(％)
熊果苷 100 68.23
实施例3 100 73.33
提取物C 100 63.62
提取物D 100 7.93
试验结果表明：人参、三七和丹参本身对酪氨酸酶没有多少抑制功效。而不添加人参、三七、丹参的组合物其酪氨酸酶抑制率是不及熊果苷的。但将两组结合在一起，酪氨酸酶抑制率高出熊果苷，可见人参、三七和丹参、以及各个组分配比对酪氨酸酶抑制能力起到了至关重要的作用，其提取物对酪氨酸激酶的抑制效果要优于现在市场上较为火热的熊果苷类产品。
试验例6 促胶原蛋白分泌实验
12孔细胞培养板上，将HDFa细胞与不同浓度的待测药物溶液混合，设置不含药物的空白照和TGF-β阳性对照。37℃，5％CO2培养3天，收取细胞培养上清，存于-80℃；加入MTS，采用MTS比色法检测490nm的OD值；按胶原蛋白ELISA试剂盒中提供的方法检测胶原蛋白的分泌，酶标仪测定OD值，检测波长为450nm。计算得到胶原蛋白分泌增加率。
胶原蛋白分泌增加率(％)＝(实验孔OD450nm/细胞存活率/空白孔OD450nm-1)×100％
表6促胶原蛋白分泌试验结果
Figure PCTCN2016073392-appb-000005
由表格得知：实例3、4、5得到的提取物均能有效促进胶原蛋白的分泌，其中实施例4的效果更为明显。
试验例7 抗皱改善试验
加入5％前述中药组合物的混合提取物(实施例5)用于配制常规眼霜，利用该乳霜涂覆眼角进行抗皱改善试验，用于评价效果。
受试者：年龄大于35岁，女性，20人，眼角有明显细纹的人群；
测试部位：眼角；
使用周期：8周；
使用方法：每日两次，早晚各一次；
测试参数：1.皮肤纹理扫描仪Visioscan VC98用于检测皮肤粗糙度SEr，平滑度SEsm和皱纹SEw；前述测定的值越小，说明皮肤粗糙度越小、皮肤越光滑、皮肤皱纹越小；2.使用问卷调查进行受试者自我评估，评分标准是：5分为“非常满意”，4分为“满意”，3分为“一般”，2分为“较不满意”，1份为“不满意”。
测试步骤：
1)清洗面部，选取左、右眼角各一个区域作为测试部位；
2)在温度21±1℃，相对试图50±5％的实验室中休息15min；
3)用VC98采集左眼角的图像并分析皮肤粗糙度SEr、皮肤光滑度SEsm和皮肤皱纹SEw：
4)问卷填写、拍照，受试者使用产品后4周和使用产品后8周还需要对测试部位皮肤进行自我评估。
测试结果如图1至图3所示，可以看出，使用了加入本发明混合提取物的化妆品后， 眼角的皮肤粗糙度、平滑度和皱纹都有明显的改善。通过答卷，90％的受试者认为皮肤状态总体有改善。

Claims (9)

  1. 一种美白抗皱中药组合物，其特征在于：包括天麻、白芨、丹皮、红花、三七、丹参、甘草、枸杞；
    其中白芨、丹参、甘草的重量占总重的30～55％。
  2. 根据权利要求1所述的一种美白抗皱中药组合物，其特征在于：枸杞不少于总重的15％，红花占总重的8～20％，天麻不超过总重的8％。
  3. 根据权利要求2所述的一种美白抗皱中药组合物，其特征在于，按质量百分比包括如下组分：
    Figure PCTCN2016073392-appb-100001
  4. 一种美白抗皱中药组合物的混合提取物，其特征在于通过如下方法获得：将权利要求1所述的中药组合物按比例混合，粉碎后醇提，回流萃取获得初浸膏；将初浸膏湿法上柱，通过硅藻土层析分离获得。
  5. 根据权利要求4所述的混合提取物，其特征在于：所述中药组合物粉碎后醇提是利用醇：水为10∶90的比例在69～90℃下提取6～8小时，提取液经过回流萃取后静置、浓缩、干燥至溶剂完全挥发。
  6. 根据权利要求5所述的混合提取物，其特征在于：通过硅藻土层析时，采用乙醇-乙酸乙酯体系，乙醇和乙酸乙酯使用的体积比为2∶1～1∶15。
  7. 根据权利要求4～6中任意一项所述的混合提取物，其特征在于：该混合提取物中甙类、糖苷类物质占总重不少于18％。
  8. 一种美白抗皱中药组合物的混合提取物，其特征在于：与DPPH反应1小时后与空白对照测定计算的抗氧化率不小于94％；0.1％g/mL时酪氨酸激酶抑制能力达到70％以上。
  9. 如权利要求1所述中药组合物在制备外用化妆品产品上的应用。
PCT/CN2016/073392 2015-12-03 2016-02-03 一种美白抗皱中药组合物及其混合提取物和应用 WO2017092176A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510875448.2 2015-12-03
CN201510875448.2A CN105288246A (zh) 2015-12-03 2015-12-03 一种美白抗皱中药组合物及其混合提取物和应用

Publications (1)

Publication Number Publication Date
WO2017092176A1 true WO2017092176A1 (zh) 2017-06-08

Family

ID=55186524

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/073392 WO2017092176A1 (zh) 2015-12-03 2016-02-03 一种美白抗皱中药组合物及其混合提取物和应用

Country Status (2)

Country Link
CN (1) CN105288246A (zh)
WO (1) WO2017092176A1 (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109512736A (zh) * 2018-11-19 2019-03-26 北京明弘科贸有限责任公司 一种护肤组合物及具有细致毛孔功效的化妆品
CN115281146A (zh) * 2022-07-08 2022-11-04 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种鸡湿热下利证模型的构建方法
CN115494181A (zh) * 2022-10-17 2022-12-20 山东省食品药品检验研究院 一种同时鉴别通络化痰胶囊中五种原料药的检测方法
CN115531281A (zh) * 2022-10-13 2022-12-30 广州健姿宝大健康产业开发有限公司 一种改善皮肤的天然组合物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106562903A (zh) * 2016-08-31 2017-04-19 宁夏清华园知识产权研究与开发有限公司 一种利用鸡蛋进行孵化的美容养颜制品
CN107375034A (zh) * 2017-08-17 2017-11-24 成都新柯力化工科技有限公司 一种抗皮肤老化的化妆品及其制备方法
CN108635303A (zh) * 2018-08-05 2018-10-12 王忠良 一种亮白抗衰化妆品组合物及其制备方法
CN115120529B (zh) * 2022-06-17 2023-10-24 山东农业大学 一种丹参红花复合多糖及其制备方法和应用
CN117815110B (zh) * 2024-03-04 2024-05-14 广东药科大学 一种保湿舒缓美白植物复方多糖及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1439357A (zh) * 2003-02-21 2003-09-03 郑延明 百草琼浆护肤膏及其制备方法
CN101744756A (zh) * 2008-12-17 2010-06-23 马桂珍 一种中药多效美肤霜及其制备方法
CN103372178A (zh) * 2012-04-12 2013-10-30 王海涛 一种药物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101062002B (zh) * 2006-04-24 2010-06-16 王筑平 含植物提取物的护肤组合物
CN102205055B (zh) * 2011-06-09 2013-01-30 王明全 一种肌肤修复用药物及制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1439357A (zh) * 2003-02-21 2003-09-03 郑延明 百草琼浆护肤膏及其制备方法
CN101744756A (zh) * 2008-12-17 2010-06-23 马桂珍 一种中药多效美肤霜及其制备方法
CN103372178A (zh) * 2012-04-12 2013-10-30 王海涛 一种药物及其制备方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109512736A (zh) * 2018-11-19 2019-03-26 北京明弘科贸有限责任公司 一种护肤组合物及具有细致毛孔功效的化妆品
CN115281146A (zh) * 2022-07-08 2022-11-04 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种鸡湿热下利证模型的构建方法
CN115531281A (zh) * 2022-10-13 2022-12-30 广州健姿宝大健康产业开发有限公司 一种改善皮肤的天然组合物
CN115494181A (zh) * 2022-10-17 2022-12-20 山东省食品药品检验研究院 一种同时鉴别通络化痰胶囊中五种原料药的检测方法
CN115494181B (zh) * 2022-10-17 2024-05-17 山东省食品药品检验研究院 一种同时鉴别通络化痰胶囊中五种原料药的检测方法

Also Published As

Publication number Publication date
CN105288246A (zh) 2016-02-03

Similar Documents

Publication Publication Date Title
WO2017092176A1 (zh) 一种美白抗皱中药组合物及其混合提取物和应用
KR20210038369A (ko) 한방생물 추출물을 포함하는 탈모방지 및 발모용 세정제 조성물 및 이의 제조방법
KR20100066784A (ko) 여드름 피부 개선용 화장료 조성물
KR100813781B1 (ko) 아토피 피부염 개선능을 갖는 한방 조성물 및 그 제조방법
CN106420531B (zh) 一种含藏荆芥具有美白保湿功效的中药组合提取物及应用
KR101829892B1 (ko) 물푸레나무 추출물 및 갯메꽃 추출물을 유효성분으로 함유하는 화장료 조성물
KR20080002279A (ko) 아토피 증상 개선의 효과가 있는 입술용 화장료 조성물
KR20120041514A (ko) 한방 생약재 추출물을 포함하는 탈모방지 및 발모용 세정제 조성물 및 이의 제조방법
CN109662904A (zh) 一种具有美白抗氧化功效的护肤组合物及其应用和制备方法
CN110403880A (zh) 一种中药发酵物及其制备的护手霜
KR20130105003A (ko) 대나무 통 한방 발효 추출물을 유효 성분으로 함유하는 아토피 피부 개선 화장료 조성물 및 그의 제조방법
KR102004366B1 (ko) 중대가리풀 추출물을 유효성분으로 함유하는 화장료 조성물
CN107019657A (zh) 一种美白保湿组合物及其制备方法和使用方法
CN101234132A (zh) 当归或其提取物在制备护肤品中的新用途
KR20050052839A (ko) 생약재 추출물을 함유하는 피부 외용제 조성물
CN108836925B (zh) 一种抗干敏中药提取物的组合物和其制备方法及在化妆品中的应用
US10434057B2 (en) Cosmetic composition comprising osmanthus asiaticus extract and clematis apiifolia extract
CN110101648B (zh) 一种美容遮瑕的气垫bb霜
KR102081066B1 (ko) 한방 초고압 추출물을 유효성분으로 함유하는 피부 장벽 강화용 조성물
KR102598348B1 (ko) 피지 조절 및 모공 축소용 조성물
KR20100061090A (ko) 여드름 및 여드름양 발진 완화용 또는 치료용 화장료 조성물
KR101914969B1 (ko) 한방복합발효추출물을 함유하는 모발용 화장료 조성물
CN113456752A (zh) 一种美容组合物及其制备方法
CN102626471B (zh) 一种具有防敏脱敏、修复再生作用的中药组合物
CN109718185A (zh) 一种舒缓抗过敏的中草药组合物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16869490

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16869490

Country of ref document: EP

Kind code of ref document: A1